Dr. Jonathan A. Gutman, MD

Dr. Gutman practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Gutman's NPI, 1003882952, was assigned on February 28, 2006. Dr. Gutman graduated from New York University School of Medicine in 2002. Dr. Gutman holds Colorado license 43032.

Dr. Gutman's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Gutman's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Gutman is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Gutman to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gutman practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Gutman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Gutman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gutman's licenses on file in 2 states: Colorado and Washington.

Dmand AI lists chronic leukemia and multiple myeloma among the conditions Dr. Gutman treats.

CMS data shows 225 Medicare services from Dr. Gutman across 3 procedure codes in 2024, for 65 Medicare patients. Medicare paid $19,309 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Gutman in 2024. The largest group is 65 to 74, with 38 patients. 65% of them have high blood pressure, and 60% have high cholesterol. Their average risk score is 3.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gutman's median patient age at 68, with 39% women.

In 2024, Dr. Gutman wrote 444 Medicare Part D claims for 55 patients. 79% of them were for generic drugs. CMS names the drug for 266 of them, across 10 drugs with 11 or more claims each, at $1,109,288 in total drug cost. In 2023, CMS named 246 claims across 9 drugs.

Dr. Gutman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gutman as offering telehealth.

Dmand AI links 87 papers to Dr. Gutman, published from 2007 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Leukemia, Myeloid, Acute, Cord Blood Stem Cell Transplantation and Hematopoietic Stem Cell Transplantation. Dr. Gutman has published most often in Bone Marrow Transplant. Dr. Gutman's most frequent co-authors are Daniel Aaron Pollyea, MD, Clayton A. Smith, MD and Colleen Susanne Delaney, MD.

Dmand AI links Dr. Gutman to 18 clinical trials, 8 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute and Leukemia, Prolymphocytic. Fred Hutchinson Cancer Center sponsors the most, 7.

CMS Open Payments shows 47 general payments to Dr. Gutman from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Gamida Cell Inc. paid the most, $11,670. It also lists 1 research payment totaling $700 in 2021.

Dmand AI lists 1 award for Dr. Gutman, most recently CMS Stage 1 EHR in 2013.

Dr. Gutman graduated from New York University School of Medicine in 2002.

Dr. Gutman is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.